Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ZOLPIDEM TARTRATE
Medication labelWhy this: Advisory · dailymed-prescription
Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14)]. The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
- generic_name
- zolpidem tartrate
- product_names
- ZOLPIDEM TARTRATE
- ndc
- 61919-528, 0603-6468, 61919-528-30, 61919-528-60, 61919-528-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en